UICC

What UICC does

UICC is a Geneva-headquartered, membership-based non-profit association founded in 1933 that convenes the global cancer control community. Its primary constituents are over 1,150 member organizations spanning 170+ countries, including national cancer societies, patient advocacy groups, research institutions, hospitals, and government health bodies. UICC's portfolio covers advocacy campaigns (notably World Cancer Day on 4 February), premier conference events (World Cancer Congress, World Cancer Leaders' Summit, Cancer Planners Forum), a digital membership platform (UICC Connect), globally maintained technical standards (the TNM cancer staging classification), data programmes (Global Initiative for Cancer Registries), disease-specific initiatives (Breast Cancer Programme launched in 2020, ATOM Coalition for access to oncology medicines), and capacity-building instruments (Technical Fellowships, Young Leaders Programme, Cancer Advocates Programme, Patient Group Mentoring, and grant schemes including SPARC and Yamagiwa-Yoshida). The technology stack is non-proprietary and operational rather than product-oriented — UICC operates UICC Connect as a member-engagement platform, maintains TNM classification documentation and e-learning, publishes a podcast ("Let's Talk Cancer"), and produces documentary content with BBC StoryWorks ("Rewriting Cancer"); there is no public API, no proprietary software product, and no disclosed data flywheel.

UICC's revenue model is a mix of recurring and transactional streams typical of an international association. Membership dues from over 1,150 organizations form a recurring subscription base; event registration fees and sponsorships (World Cancer Congress, World Cancer Leaders' Summit, Cancer Planners Forum) generate transaction-based revenue; flagship GTM/marketing partnerships with global biopharmaceutical companies — AstraZeneca, Bristol-Myers Squibb, MSD, Pfizer, plus cancer research funders such as Cancer Research UK and the Dutch Cancer Society — contribute sponsorship and programme funding; and tax-deductible donations are accepted in Switzerland (CHE-107.751.349) and the USA (501(c)(3), EIN 23-7208844). The organization holds official relations with the World Health Organization and partners with multilateral agencies (IARC, IAEA, PAHO) to shape global cancer policy, including support for the WHO Global Breast Cancer Initiative and cervical cancer elimination strategies.

The organization is governed by a Board of Directors and a General Assembly of members, with Cary Adams serving as CEO. Headcount is reported in the 101–250 range. UICC has no parent company, no subsidiaries, no equity funding rounds, and no public financial disclosure; financial scale can only be triangulated from membership counts, partner breadth, and event cadence.

Name

UICC

Legal name

Union for International Cancer Control

Website

https://uicc.org

Company type

Private

Founded year

1933

Operating status

Operating

Headcount range

101–250 employees

Short description

UICC is a Geneva-based, membership-driven international non-profit founded in 1933 that convenes over 1,150 cancer organizations across 170+ countries to advance global cancer control through advocacy campaigns, conferences, knowledge standards (e.g., TNM), fellowships, and WHO-aligned policy work.

Ownership category

akta.pro rank

Product category

Global Cancer Control Advocacy and Convening

NAICS

Professional Organizations (81392), Convention and Trade Show Organizers (561920)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Association & Society Conference Management (Nonprofit, Professional Bodies) (THAHACAA)

akta.pro secondary industry

Training, Enablement & Talent Development Summits (THAHAMAH)

Keywords

• Cancer control advocacy
• Global health membership
• Cancer staging standards
• Oncology capacity building
• Non-communicable disease policy

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership fees: UICC generates revenue through membership fees from over 1,150 member organizations worldwide. Members include cancer organizations, research institutions, and patient groups that pay to join and gain access to UICC events, learning resources, and voting rights in the General Assembly.
2. Event revenue: UICC organizes major events including World Cancer Congress, World Cancer Leaders' Summit, and Cancer Planners Forum. These events generate revenue through registrations and sponsorship.
3. Partnership and sponsorship: UICC partners with over 80 organizations including pharmaceutical companies like AstraZeneca, Bristol-Myers Squibb, MSD, and Pfizer, who provide sponsorship and support for UICC initiatives and programs.
4. Donations: As a registered non-profit association, UICC accepts donations which are tax-deductible in select countries including Switzerland (CHE-107.751.349) and USA (501(c)(3) status, EIN 23-7208844).

Distribution channels5 records

Marketing channels10 records

Core offering

UICC is a membership-based non-profit organization that convenes the global cancer community through awareness campaigns (World Cancer Day), international conferences (World Cancer Congress, World Cancer Leaders' Summit), knowledge standards (TNM cancer staging), capacity-building programmes (fellowships, grants, advocacy training), and policy advocacy in partnership with WHO. Its offerings serve cancer societies, research institutions, patient groups, and policymakers across 170+ countries.

Product overview

UICC (Union for International Cancer Control) operates as a membership-based non-profit organization providing a portfolio of advocacy campaigns, international conferences, digital platforms, and capacity-building programmes for the global cancer control community. The offering includes awareness initiatives (World Cancer Day), premier conference events (World Cancer Congress, World Cancer Leaders' Summit, Cancer Planners Forum), a membership digital platform (UICC Connect), knowledge standards (TNM cancer staging), data programmes (Global Initiative for Cancer Registries), access initiatives (ATOM Coalition), disease-specific programmes (Breast Cancer Programme), professional development offerings (Technical Fellowships, Young Leaders Programme, Online Learning), grant programmes (SPARC), advocacy and mentorship programmes (Cancer Advocates, Patient Group Mentoring), and content platforms (Let's Talk Cancer Podcast). The organization does not offer a unified software product but rather serves as a convening, advocacy, and knowledge-sharing body for over 1,150 member organizations across the cancer control ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• World Cancer Day: A global initiative led by UICC to raise awareness about cancer and promote its prevention, detection, and treatment.
• World Cancer Congress
• World Cancer Leaders' Summit
• UICC Connect
• ATOM Coalition
• City Cancer Challenge (C/Can)
• Young Leaders Programme

Products and services

• World Cancer Day

Quantifiable outcome

• WHO Global Breast Cancer Initiative aims to reduce breast cancer deaths by 2.5% per year, potentially saving 2.5 million lives over 20 years
• +5 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core, flagship and minor.

• World Health Organization (WHO)coreStrategic or Co-development PartnerUICC works closely with WHO on global cancer control initiatives including the Global Breast Cancer Initiative, cervical cancer elimination strategy, and universal health coverage. UICC serves as a key civil society partner in advancing WHO cancer resolutions and global health commitments.
• International Agency for Research on Cancer (IARC)coreStrategic or Co-development PartnerIARC is a specialized cancer research agency that provides global cancer statistics and evidence that informs UICC's programs and advocacy work.
• International Atomic Energy Agency (IAEA)coreStrategic or Co-development PartnerIAEA collaborates with UICC on cancer control, particularly around radiotherapy access and nuclear medicine in low-resource settings.
• AstraZenecaflagshipGTM or Marketing PartnerAstraZeneca is a global, science-led biopharmaceutical company and UICC partner. They focus on Oncology, Cardiovascular & Metabolic Diseases, and Respiratory. Operating in over 100 countries with innovative medicines used by millions of patients worldwide.
• Bristol-Myers SquibbflagshipGTM or Marketing PartnerGlobal BioPharma company focused on discovering, developing and delivering innovative medicines to patients with serious diseases, including cancer.
• Cancer Research UKflagshipGTM or Marketing PartnerWorld's largest independent funder of cancer research. Vision is to bring forward the day when all cancers are cured. Invests $500m annually in world-leading research across all 200 different types of cancer. Became a full UICC member in 1986.
• Dutch Cancer Society (KWF Kankerbestrijding)flagshipGTM or Marketing PartnerNation-wide organization for cancer control in the Netherlands, founded in 1949 by Queen Wilhelmina. Ideal is a world where nobody dies from cancer. Funded by over 1 million donors with nearly 1,500 local committees.
• MSDflagshipGTM or Marketing PartnerGlobal biopharmaceutical company inventing for life for challenging diseases. Operates in more than 140 countries delivering innovative health solutions including cancer treatments.
• PfizerflagshipGTM or Marketing PartnerGlobal pharmaceutical company applying science and resources to bring therapies that extend and improve lives. Works across developed and emerging markets in oncology and healthcare.
• City Cancer Challenge (C/Can)coreStrategic or Co-development PartnerC/Can supports cities to accelerate their cancer care response through a network of cities, institutions, and experts working to improve access to quality cancer care.
• International Cancer Control Partnership (ICCP)coreStrategic or Co-development PartnerPartnership supporting countries in developing, implementing, and evaluating national cancer control plans.
• McCabe Centre for Law and CancercoreStrategic or Co-development PartnerInternational center focused on law and cancer control, helping countries use law and policy to prevent cancer and improve cancer care.
• NCD AlliancecoreStrategic or Co-development PartnerGlobal civil society network dedicated to preventing and controlling non-communicable diseases, including cancer as a major NCD.
• BBC StoryWorkscoreGTM or Marketing PartnerProduction partner for the Rewriting Cancer film series, creating documentaries that showcase progress and challenges in global cancer care. First series released in 2024, second series in 2026.
• Clean Air FundminorGTM or Marketing PartnerPartner supporting UICC's clean air and cancer control initiatives with funding for air pollution and cancer research.
• NCI Center for Global HealthcoreStrategic or Co-development PartnerPartner in breast cancer initiatives including jointly producing Knowledge Summaries for Comprehensive Breast Cancer Control with UICC.
• Breast Health Global Initiative (BHGI)coreStrategic or Co-development PartnerCollaborative partner in breast cancer control programs, developing resource-stratified guidelines for breast cancer care in low-resource settings.
• PAHO (Pan American Health Organization)coreStrategic or Co-development PartnerUN specialized health agency in the Americas, jointly producing breast cancer knowledge summaries with UICC and partners.
• Pfizer OncologyflagshipGTM or Marketing PartnerPartner in the SPARC MBC Challenge (2015-2021), a global grant initiative supporting organizations addressing metastatic breast cancer patient needs. SPARC awarded $1,580,000 in grants to over 50 organizations from 35 countries.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• American Cancer Society: Large national cancer control and advocacy organization with similar portfolio (research funding, patient support, advocacy, convening). Comparable as a peer membership/NGO structure serving overlapping cancer-control stakeholders, though geographically concentrated in the US.
• Cancer Research UK: World's largest independent cancer research funder and a long-standing UICC member. Comparable mission (research funding, advocacy, patient support) at national scale; a partner as well as a peer for global convening positioning.
• European Cancer Organisation: Umbrella cancer organization in Europe focused on policy, convening, and multidisciplinary collaboration across the cancer care continuum. Closely mirrors UICC's convening-and-advocacy model at a regional level.
• American Association for Cancer Research (AACR): Professional society for cancer researchers running major scientific meetings, journals, and grants programs. Overlaps with UICC on the scientific-convening and knowledge-dissemination side of cancer control.
• American Society of Clinical Oncology (ASCO): Premier oncology professional association running global conferences (ASCO Annual Meeting), clinical guidelines, and member education. Directly comparable in operating a large oncology professional membership and convening business.
• NCD Alliance: Global civil-society network for non-communicable diseases including cancer. Mirrors UICC's convening-plus-advocacy model for a broader NCD mandate; UICC and NCD Alliance are listed mutual partners.

Emerging players

• National Comprehensive Cancer Network (NCCN): Alliance of leading cancer centers producing globally referenced clinical practice guidelines. Comparable as a knowledge-standards authority in oncology, complementing UICC's TNM and cancer-registry work.
• Clinton Health Access Initiative (CHAI): Global health implementation organization active in cancer medicines access and LMIC health systems. Comparable in advancing access-to-medicines mandates that intersect with UICC's ATOM Coalition mission.

Broad incumbents

• World Health Organization (WHO): UN specialized health agency that sets global cancer policy (Global Breast Cancer Initiative, cervical cancer elimination). Functions as UICC's principal policy counterpart and convening partner rather than a direct competitor.
• International Agency for Research on Cancer (IARC): WHO's specialized cancer research agency providing global cancer statistics that anchor UICC's data and registry programs. Strategic data counterpart rather than a competing membership organization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/uicc
• LinkedInlinkedin.com/company/uicc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UICC